Search results
Results from the WOW.Com Content Network
They are also used to remove potassium, calcium, and sodium from solutions in technical applications. Common side effects include loss of appetite, gastrointestinal upset, constipation, and low blood calcium. [1] These polymers are derived from polystyrene by the addition of sulfonate functional groups.
Potassium binders are medications that bind potassium ions in the gastrointestinal tract, thereby preventing its intestinal absorption. This category formerly consisted solely of polystyrene sulfonate, a polyanionic resin attached to a cation, administered either orally or by retention enema to patients who are at risk of developing hyperkalaemia (abnormal high serum potassium levels).
Calcium citrate is recommended for patients with achlorhydria and those on medications that decrease stomach acidity. While calcium carbonate is the most common and least expensive form of calcium and contains 40% of elemental calcium, calcium citrate supplements contain only 21% calcium, requiring more tablets for equivalent dosage.
Caltrate [1] is a brand name calcium supplement sold by Haleon. The brand was originally owned by Pfizer (formerly Wyeth) and GSK and in Japan by Hisamitsu Pharmaceutical. The Caltrate brand is supplied in many different formulas; calcium carbonate (NOT calcium citrate) is the common ingredient serving as the calcium supplement source. [2]
Centrum is an American brand of multivitamins produced by Haleon. It was designed by Dr. Ellenbogen's team, working at Lederle Laboratories, and was introduced in 1978. It has been owned by Wyeth, Pfizer, GSK. [1], and now Haleon. Centrum multivitamins in Australasian packaging
Cinacalcet, sold under the brand name Sensipar among others, is a medication used to treat primary hyperparathyroidism, tertiary hyperparathyroidism and parathyroid carcinoma. [ 4 ] [ 6 ] [ 5 ] Cinacalcet acts as a calcimimetic (i.e., it mimics the action of calcium on tissues ) by allosteric activation of the calcium-sensing receptor that is ...
Flunarizine is a selective calcium antagonist with moderate other actions including antihistamine, serotonin receptor blocking and dopamine D 2 blocking activity. Compared to other calcium channel blockers such as dihydropyridine derivatives, verapamil and diltiazem, flunarizine has low affinity to voltage-dependent calcium channels.
Patiromer works by binding free potassium ions in the gastrointestinal tract and releasing calcium ions for exchange, thus lowering the amount of potassium available for absorption into the bloodstream and increasing the amount that is excreted via the feces. The net effect is a reduction of potassium levels in the blood serum. [4] [11]